Updated Date:
11 May 2026
Product Detail:
EPREX epoetin alfa (rch) 6000IU/0.6mL injection syringe
Shortage Status:
Discontinued
AUST R:
76971
Availability:
Reduction in supply until supply is exhausted
Active Ingredient:
Epoetin alfa
Reason:
Commercial Changes / Commercial viability
Dosage Form:
Injection,solution
Supply Impact Dates
Management Action:
The sponsor will continue to supply until the market deletion date.
Patients are advised to consult their health professional to discuss alternative treatment options.